Estrogens Conjugated 1.25 MG Tab (Premarin)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care.
Formulary Restrictions:
MEDICAL DIRECTOR APPROVAL REQUIRED IF USED FOR GENDER CHANGE, ALL HORMONAL THERAPY BY INMATES UPON ADMISSION INTO THE BOP TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE APPROVED BY THE MEDICAL DIRECTOR ALL DOSAGE CHANGES (INCREASE OR DECREASE)
FOR HORMONAL THERAPY TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE PRE-APPROVED BY THE MEDICAL DIRECTOR UTILIZATION IN
SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL REFER TO PARAPHILIA TREATMENT GUIDELINE
Estradiol Valerate 10 MG/ML IM Inj (Delestrogen)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care
Formulary Restrictions:
UTILIZATION IN SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL. REFER TO PARAPHILIA TREATMENT GUIDELINES
Estrogens Conjugated 1.25 MG Tab UD (Premarin)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care.
Formulary Restrictions:
MEDICAL DIRECTOR APPROVAL REQUIRED IF USED FOR GENDER CHANGE, ALL HORMONAL THERAPY BY INMATES UPON ADMISSION INTO THE BOP TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE APPROVED BY THE MEDICAL DIRECTOR ALL DOSAGE CHANGES (INCREASE OR DECREASE)
FOR HORMONAL THERAPY TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE PRE-APPROVED BY THE MEDICAL DIRECTOR UTILIZATION IN
SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL REFER TO PARAPHILIA TREATMENT GUIDELINE
Estradiol Valerate 20 MG/ML IM inj (Delestrogen)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care
Formulary Restrictions:
UTILIZATION IN SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL. REFER TO PARAPHILIA TREATMENT GUIDELINES
Estrogens Esterified 0.3 MG Tab (Menest)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care.
Formulary Restrictions:
MEDICAL DIRECTOR APPROVAL REQUIRED IF USED FOR GENDER CHANGE, ALL HORMONAL THERAPY BY INMATES UPON ADMISSION INTO THE BOP TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE APPROVED BY THE MEDICAL DIRECTOR ALL DOSAGE CHANGES (INCREASE OR DECREASE)
FOR HORMONAL THERAPY TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE PRE-APPROVED BY THE MEDICAL DIRECTOR UTILIZATION IN
SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL REFER TO PARAPHILIA TREATMENT GUIDELINE
Estradiol Valerate 40 MG/ML IM Inj (Delestrogen)
Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care
Formulary Restrictions:
UTILIZATION IN SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL. REFER TO PARAPHILIA TREATMENT GUIDELINES